Llwytho...
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
BACKGROUND: Although immune modulation is a promising therapeutic avenue in coronavirus disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar characteristics and outcomes, suggesting a unique immunopathogenesis. METHODS: Thirty-six immunocompetent non-COVID-19...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Transl Med |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7711269/ https://ncbi.nlm.nih.gov/pubmed/33272291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02646-9 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|